ALK4290 - CAS 1251528-23-0

ALK4290 (AKST4290) is a potent, orally active CCR3 inhibitor (compound Example 2) with a Ki of 3.2 nM for hCCR3[1], suitable for research into neovascular age-related macular degeneration and Parkinsonism[2][3].

Others, CCR

Others, Immunology/Inflammation, Microbiology/Virology, GPCR/G Protein

1251505

C27H34ClN5O3

512.04

CN(C)C(=O)c1cc(C)nc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1

-20°C

Ice Packs

Small Compound